We are live on
!
Find out more
VLKIM
Van Lanschot Kempen Investment Management Portfolio holdings
AUM
$11.4B
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+12.73%
1 Year Est. Return
+16.77%
3 Year Est. Return
+63.28%
5 Year Est. Return
+82.06%
10 Year Est. Return
+190.54%
AUM
$10.5B
AUM Growth
+$920M
(+9.6%)
Cap. Flow
-$64.6M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
40.97%
Holding
262
New
34
Increased
109
Reduced
86
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$100M |
| 2 |
Lennar Class A
LEN
|
+$88.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$82.1M |
| 4 |
Littelfuse
LFUS
|
+$65.8M |
| 5 |
KKR & Co
KKR
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$150M |
| 2 |
Medtronic
MDT
|
+$149M |
| 3 |
Avantor
AVTR
|
+$89.3M |
| 4 |
Mastercard
MA
|
+$42.5M |
| 5 |
Huntington Bancshares
HBAN
|
+$36.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.31% |
| 2 | Financials | 21.4% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Communication Services | 13.1% |
| 5 | Healthcare | 8.01% |
Similar funds
ERSOT
GKIM
DWM
BHCM
DCP
BCI
VA
Van Lanschot Kempen Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, Van Lanschot Kempen Investment Management held 262 positions worth $10.5B, up 9.6% from $9.58B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Van Lanschot Kempen Investment Management's Q2 2025 filing shows 34 new, 109 increased, 86 reduced and 23 closed positions. Its largest new stake was NVR: 13,962 shares worth $103M. The largest sale was Johnson & Johnson, an estimated $150M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Van Lanschot Kempen Investment Management's largest Q2 2025 buy was NVR: 13,962 shares worth $103M.
- Van Lanschot Kempen Investment Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $82.1M increase.
- Van Lanschot Kempen Investment Management's biggest Q2 2025 reduction was Medtronic, cutting an estimated $149M.
- Van Lanschot Kempen Investment Management fully exited Johnson & Johnson in Q2 2025, selling an estimated $150M.
- Van Lanschot Kempen Investment Management's ten largest holdings make up 41% of its $10.5B portfolio in Q2 2025.
- Van Lanschot Kempen Investment Management opened 34 new positions and closed 23 in Q2 2025.
- Van Lanschot Kempen Investment Management's portfolio value rose 9.6% quarter-over-quarter to $10.5B.
Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.